UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Cancer, 2020-11, Vol.126 (22), p.4948-4956

2020

Volltextzugriff (PDF)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Journal of ovarian research, 2022-11, Vol.15 (1), p.120-17, Article 120

2022

Volltextzugriff (PDF)

Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers

International journal of gynecological cancer, 2021-11, Vol.31 (11), p.1403-1407

2021

Volltextzugriff (PDF)

Mesothelium expression of vascular cell adhesion molecule‐1 (VCAM‐1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC)

Cancer, 2017-03, Vol.123 (6), p.977-984

2017

Volltextzugriff (PDF)

Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?

Gynecologic oncology, 2017-05, Vol.145 (2), p.329-333

2017

Volltextzugriff (PDF)

A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer

International journal of gynecological cancer, 2023-09, Vol.33 (9), p.1458-1463

2023

Volltextzugriff (PDF)

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin

Gynecologic oncology, 2014-02, Vol.132 (2), p.455-461

2014

Volltextzugriff (PDF)

The revolving door: Hospital readmissions of gynecologic oncology patients

Gynecologic oncology, 2011-09, Vol.122 (3), p.479-483

2011

Volltextzugriff (PDF)

Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer

Journal of Nuclear Medicine, 2013-11, Vol.54 (11), p.1883-1889

2013

Volltextzugriff (PDF)

Para-aortic Lymph Node Dissection for Women With Endometrial Adenocarcinoma and Intermediate- to High-Risk Tumors: Does It Improve Survival?

International journal of gynecological cancer, 2014-01, Vol.24 (1), p.91-96

2014

Volltextzugriff (PDF)

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

The lancet oncology, 2017-03, Vol.18 (3), p.384-392

2017

Volltextzugriff (PDF)

A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma

Gynecologic oncology, 2024-09, Vol.188, p.13-21

2024

Volltextzugriff (PDF)

Abstract 1213: PDE10A as a novel target to suppress Wnt/β-catenin signaling and other oncogenic pathways in ovarian cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1213-1213

2021

Volltextzugriff (PDF)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress [beta]-catenin and RAS signaling in epithelial ovarian cancer

Journal of ovarian research, 2022-11, Vol.15 (1)

2022

Volltextzugriff (PDF)

Abstract 848: VCAM-1 expression in epithelial ovarian cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.848-848

2010

Volltextzugriff (PDF)

Abstract 2346: Contribution of VLA-4 to ovarian cancer metastasis and platinum resistance

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2346-2346

2010

Volltextzugriff (PDF)

Abstract A62: Imaging the tumor micro-environment to monitor ovarian cancer metastasis

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.A62-A62

2013

Volltextzugriff (PDF)

Abstract 845: Vascular cell adhesion molecule-1 (VCAM-1) expression in patients with ovarian tumors of low malignant potential

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.845-845

2010

Volltextzugriff (PDF)

THE INFLUENCE OF ESTRADIOL AND DIHYDROTESTOSTERONE ON POST-TRAUMATIC INFLAMMATORY CYTOKINE LEVELS

The journal of trauma, 2004-08, Vol.57 (2), p.452

2004

Volltextzugriff (PDF)

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Oncogene, 2017-11, Vol.36 (48), p.6680-6690

2017

Volltextzugriff (PDF)

Validation of a venous thromboembolism risk assessment model in gynecologic oncology

Gynecologic oncology, 2014-07, Vol.134 (1), p.160-163

2014

Volltextzugriff (PDF)

Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity

Gynecologic oncology, 2020-06, Vol.157 (3), p.729-732

2020

Volltextzugriff (PDF)

Perivascular epithelioid cell tumor (PEComa) of the uterus: Challenges of pregnancy in determining prognosis and optimal treatment

Gynecologic oncology reports, 2022-04, Vol.40, p.100962, Article 100962

2022

Volltextzugriff (PDF)

A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen

Gynecologic oncology, 2022-01, Vol.164 (1), p.181-186

2022

Volltextzugriff (PDF)

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes

Gynecologic oncology, 2022-09, Vol.166 (3), p.417-424

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(16)
Humans
(16)
Oncology
(14)
Ovarian Cancer
(12)
Obstetrics & Gynecology
(11)
Middle Aged
(8)
Chemotherapy
(7)
Cancer
(6)
Retrospective Studies
(6)
Adult
(5)
Carcinoma, Ovarian Epithelial
(5)
Hematology, Oncology And Palliative Medicine
(5)
Metastasis
(5)
Ovarian Neoplasms - Drug Therapy
(5)
Ovarian Neoplasms - Pathology
(5)
Aged
(4)
Cancer Therapies
(4)
Cell Line, Tumor
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers

Mesothelium expression of vascular cell adhesion molecule‐1 (VCAM‐1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC)

Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?

A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin

The revolving door: Hospital readmissions of gynecologic oncology patients

Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer

Para-aortic Lymph Node Dissection for Women With Endometrial Adenocarcinoma and Intermediate- to High-Risk Tumors: Does It Improve Survival?

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma

Abstract 1213: PDE10A as a novel target to suppress Wnt/β-catenin signaling and other oncogenic pathways in ovarian cancer

Phosphodiesterase 10A (PDE10A) as a novel target to suppress [beta]-catenin and RAS signaling in epithelial ovarian cancer

Abstract 848: VCAM-1 expression in epithelial ovarian cancer

Abstract 2346: Contribution of VLA-4 to ovarian cancer metastasis and platinum resistance

Abstract A62: Imaging the tumor micro-environment to monitor ovarian cancer metastasis

Abstract 845: Vascular cell adhesion molecule-1 (VCAM-1) expression in patients with ovarian tumors of low malignant potential

THE INFLUENCE OF ESTRADIOL AND DIHYDROTESTOSTERONE ON POST-TRAUMATIC INFLAMMATORY CYTOKINE LEVELS

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Validation of a venous thromboembolism risk assessment model in gynecologic oncology

Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity

Perivascular epithelioid cell tumor (PEComa) of the uterus: Challenges of pregnancy in determining prognosis and optimal treatment

A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes

Suchergebnisse filtern